PHASE-II STUDY OF AMSACRINE AND HIGH-DOSE CYTARABINE FOR RESISTANT ACUTE MYELOGENOUS LEUKEMIA

被引：0
|
作者：
DECKER, RW
HO, WG
CHAMPLIN, RE
机构：
[1] UNIV CALIF LOS ANGELES,CTR HLTH SCI,SCH MED,DEPT MED,DIV HEMATOL ONCOL,TRANSPLANTAT BIOL PROGRAM,LOS ANGELES,CA 90024
[2] UNIV CALIF LOS ANGELES,CTR HLTH SCI,SCH MED,JONSSON COMPREHENS CANC CTR,LOS ANGELES,CA 90024
来源：
CANCER TREATMENT REPORTS | 1987年 / 71卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：881 / 882
页数：2
相关论文
共 50 条
  • [21] HIGH-DOSE CYTARABINE AND DAUNORUBICIN INDUCTION AND POSTREMISSION CHEMOTHERAPY FOR THE TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA IN ADULTS
    PHILLIPS, GL
    REECE, DE
    SHEPHERD, JD
    BARNETT, MJ
    BROWN, RA
    FREILAHR, DA
    KLINGEMANN, HG
    BOLWELL, BJ
    SPINELLI, JJ
    HERZIG, RH
    HERZIG, GP
    [J]. BLOOD, 1991, 77 (07) : 1429 - 1435
  • [22] AMSACRINE WITH HIGH-DOSE CYTARABINE IS HIGHLY EFFECTIVE THERAPY FOR REFRACTORY AND RELAPSED ACUTE LYMPHOBLASTIC-LEUKEMIA IN ADULTS
    ARLIN, ZA
    FELDMAN, E
    KEMPIN, S
    AHMED, T
    MITTELMAN, A
    SAVONA, S
    ASCENSAO, J
    BASKIND, P
    SULLIVAN, P
    FUHR, HG
    MERTELSMANN, R
    [J]. BLOOD, 1988, 72 (02) : 433 - 435
  • [23] A PHASE-II, HIGH-DOSE STUDY OF NALOXONE IN TREATMENT OF ACUTE CEREBRAL INFARCTION
    OLINGER, CP
    ADAMS, HP
    BROTT, TG
    BILLER, J
    BARSAN, WP
    [J]. CIRCULATION, 1987, 76 (04) : 144 - 144
  • [24] PHASE-II STUDY OF LOW-DOSE CONTINUOUS INFUSION HOMOHARRINGTONINE IN REFRACTORY ACUTE MYELOGENOUS LEUKEMIA
    KANTARJIAN, HM
    KEATING, MJ
    WALTERS, RS
    KOLLER, CA
    MCCREDIE, KB
    FREIREICH, EJ
    [J]. CANCER, 1989, 63 (05) : 813 - 817
  • [25] PHASE-II STUDY OF TREATMENT OF REFRACTORY ACUTE-LEUKEMIA WITH INTERMEDIATE-DOSE CYTOSINE-ARABINOSIDE AND AMSACRINE
    JEHN, U
    HEINEMANN, V
    [J]. ANNALS OF HEMATOLOGY, 1993, 66 (03) : 131 - 134
  • [26] A randomized study of high-dose cytarabine in induction in acute myeloid leukemia
    Bishop, JF
    Matthews, JP
    Young, GA
    Szer, J
    Gillett, A
    Joshua, D
    Bradstock, K
    Enno, A
    Wolf, MM
    Fox, R
    Cobcroft, R
    Herrmann, R
    VanDerWeyden, M
    Lowenthal, RM
    Page, F
    Garson, OM
    Juneja, S
    [J]. BLOOD, 1996, 87 (05) : 1710 - 1717
  • [27] Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia
    Zeidner, Joshua F.
    Vincent, Benjamin G.
    Ivanova, Anastasia
    Moore, Dominic
    McKinnon, Karen P.
    Wilkinson, Alec D.
    Mukhopadhyay, Rupkatha
    Mazziotta, Francesco
    Knaus, Hanna A.
    Foster, Matthew C.
    Coombs, Catherine C.
    Jamieson, Katarzyna
    Van Deventer, Hendrik
    Webster, Jonathan A.
    Prince, Gabrielle T.
    DeZern, Amy E.
    Smith, B. Douglas
    Levis, Mark J.
    Montgomery, Nathan D.
    Luznik, Leo
    Serody, Jonathan S.
    Gojo, Ivana
    [J]. BLOOD CANCER DISCOVERY, 2021, 2 (06): : 616 - 629
  • [28] High-dose cytarabine induction for acute myeloid leukemia
    Shepherd, JD
    Barnett, MJ
    Phillips, GL
    [J]. BLOOD, 1996, 88 (02) : 754 - 754
  • [29] PHASE-II TRIAL OF ACLACINOMYCIN IN ACUTE MYELOGENOUS LEUKEMIA (AML)
    CASE, DC
    BOYD, M
    BOVE, LG
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 176 - 176
  • [30] PHASE-II TRIAL OF PLICAMYCIN AND HYDROXYUREA IN ACUTE MYELOGENOUS LEUKEMIA
    ARCHIMBAUD, E
    TRONCY, J
    SEBBAN, C
    GUYOTAT, D
    DEVAUX, Y
    FRENCH, M
    MORICEAU, M
    VIALA, JJ
    FIERE, D
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 25 (03) : 223 - 225
12345